Pharmaceutical executives took a verbal beating, but didn’t concede much in a high-profile testimony before the Senate Finance Committee.
Pharma CEOs survive Senate grilling with few concessions
Pharmaceutical executives took a verbal beating, but didn’t concede much in a high-profile testimony before the Senate Finance Committee.